Martin J. Cummins resigned as Vice President of Clinical and Regulatory Affairs from Amarillo Biosciences Inc., effective August 31, 2013.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.88 USD | +7.29% |
|
+9.97% | -57.07% |
1st Jan change | Capi. | |
---|---|---|
-57.07% | 5.72M | |
+18.15% | 124B | |
+18.02% | 112B | |
+5.07% | 22.94B | |
-12.75% | 22.22B | |
-9.86% | 17.02B | |
-14.97% | 16.88B | |
-39.94% | 16.87B | |
+2.80% | 13.63B | |
+27.39% | 11.61B |
- Stock Market
- Equities
- AIMD Stock
- News Ainos, Inc.
- Amarillo Biosciences Inc. Announces Resignation of Martin J. Cummins as Vice President of Clinical and Regulatory Affairs